Highlights
NASDAQ: EIGR       Eiger Biopharma
Last Price Today's Change   Day's Range   Trading Volume
9.27   -0.43 (4.43%)  8.87 - 10.38  126,500

Overview

 
Avg Volume (4 weeks):192,714
4 Weeks Range:8.87 - 12.50
4 Weeks Price Volatility (%):
11.02%
52 Weeks Range:7.46 - 18.00
52 Weeks Price Volatility (%):
17.17%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases. The company’s pipeline includes five Phase 2 development programs addressing four distinct orphan diseases. The pipeline includes lonafarnib for Hepatitis Delta Virus, or HDV, PEG-interferon lambda-1a (lambda) for HDV, exendin 9-39 for Post-Bariatric Hypoglycemia, or PBH and ubenimex for Pulmonary Arterial Hypertension, or PAH and lymphedema.

  Be the first to like this.
 


 

1992  5838  722  171 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 DGAZ 2.86-3.58 
 GE 8.32-0.29 
 HMNY 0.02+0.003 
 SPY 270.20-1.86 
 AMD 20.81+1.20 
 XLF 26.37-0.36 
 EEM 39.93+0.24 
 BHGE 23.15-0.65 
 QQQ 165.20-1.27 
 BAC 27.21-0.55 
Partners & Brokers